Idorsia Ltd logo

Idorsia Ltd

SIX:IDIA.SW

Overview | Financials
Company Name Idorsia Ltd
Symbol IDIA.SW
Currency CHF
Price 1.524
Market Cap 274,441,158
Dividend Yield 0%
52-week-range 1.294 - 3.79
Industry Biotechnology
Sector Healthcare
CEO Mr. Jean-Paul Clozel M.D.
Website https://www.idorsia.com

An error occurred while fetching data.

About Idorsia Ltd

Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to

Related Stocks

Siegfried Holding AG logo

Siegfried Holding AG

SFZN.SW

1,160 CHF

BB Biotech AG logo

BB Biotech AG

BION.SW

36.75 CHF

PolyPeptide Group AG logo

PolyPeptide Group AG

PPGN.SW

31.95 CHF

Medacta Group SA logo

Medacta Group SA

MOVE.SW

122.4 CHF

Ypsomed Holding AG logo

Ypsomed Holding AG

YPSN.SW

417.5 CHF

Galenica AG logo

Galenica AG

GALE.SW

72.9 CHF

Aevis Victoria SA logo

Aevis Victoria SA

AEVS.SW

14 CHF

Tecan Group AG logo

Tecan Group AG

TECN.SW

278.4 CHF

Medartis Holding AG logo

Medartis Holding AG

MED.SW

58.3 CHF

Financials

Numbers are in millions USD

Numbers are in millions USD